Literature DB >> 20685002

How ephedrine escaped regulation in the United States: a historical review of misuse and associated policy.

Joseph Palamar1.   

Abstract

OBJECTIVE: Ephedrine is not only efficacious in the treatment of numerous ailments, but also has a long history of misuse. Research was needed to examine ephedrine policy over time in order to determine potential regulatory flaws that allowed misuse to continue.
METHODS: This review is based on primary literature derived from systematic searches of historical and scientific archives, as well as grey literature.
RESULTS: Ephedrine managed to pass through numerous regulatory loopholes within seventy years. Despite warnings of misuse over the latter half of the century, ephedrine, and its herbal source, ephedra, were regulated in a piecemeal fashion and remained easily available to the public. Health authorities have struggled to control ephedrine, as an amphetamine "look-alike," as a methamphetamine precursor, as a dietary supplement, and as a medication. Despite being a potentially dangerous stimulant, under-regulation was perhaps more problematic than the substance itself.
CONCLUSIONS: Tighter control of all ephedrine products, drugs and dietary supplements alike, might have prevented adverse outcomes and allowed this substance to remain available in a safer manner. Stringent regulation of all ephedrine products is necessary to prevent misuse and to protect the public's health.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685002     DOI: 10.1016/j.healthpol.2010.07.007

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  6 in total

1.  Development of a Genus-Universal Nucleotide Signature for the Identification and Supervision of Ephedra-Containing Products.

Authors:  Gang Wang; Xuanjiao Bai; Xiaochen Chen; Ying Ren; Jianping Han
Journal:  Molecules       Date:  2022-04-06       Impact factor: 4.411

Review 2.  Unhealthy weight control practices: culprits and clinical recommendations.

Authors:  Zachary Michael Ferraro; Sean Patterson; Jean-Philippe Chaput
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2015-02-17

Review 3.  Analytical Challenges and Metrological Approaches to Ensuring Dietary Supplement Quality: International Perspectives.

Authors:  Alessandra Durazzo; Barbara C Sorkin; Massimo Lucarini; Pavel A Gusev; Adam J Kuszak; Cindy Crawford; Courtney Boyd; Patricia A Deuster; Leila G Saldanha; Bill J Gurley; Pamela R Pehrsson; James M Harnly; Aida Turrini; Karen W Andrews; Andrea T Lindsey; Michael Heinrich; Johanna T Dwyer
Journal:  Front Pharmacol       Date:  2022-01-11       Impact factor: 5.810

4.  The Safety and Efficacy of Citrus aurantium (Bitter Orange) Extracts and p-Synephrine: A Systematic Review and Meta-Analysis.

Authors:  Dorottya Koncz; Barbara Tóth; Muh Akbar Bahar; Orsolya Roza; Dezső Csupor
Journal:  Nutrients       Date:  2022-09-28       Impact factor: 6.706

5.  Molecular dynamic simulations reveal suboptimal binding of salbutamol in T164I variant of β2 adrenergic receptor.

Authors:  Srinivas Bandaru; Mallika Alvala; Anuraj Nayarisseri; Saphy Sharda; Himshikha Goud; Hema Prasad Mundluru; Sanjeev Kumar Singh
Journal:  PLoS One       Date:  2017-10-20       Impact factor: 3.240

Review 6.  Regulatory analysis on the medical use of ephedrine-related products in Taiwan.

Authors:  Wan-Nan Yu; Li-Hsuan Wang; Hui-Wen Cheng
Journal:  J Food Drug Anal       Date:  2017-12-02       Impact factor: 6.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.